News
Company news 
ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
Company news 
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
Company news 
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
Company news 
Oxford Nanopore releases new protocol for sequencing complete microbial isolate genomes ahead of ESCMID
Company news 
Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
Company news 
Oxford Nanopore, Yemaachi Biotech, and Global Partners Collaborate to Improve Childhood Leukemia Outcomes in Ghana
Company news 
Nanopore sequencing demonstrates identification of antibiotic-resistant pathogens hidden to traditional methods in new study
Company news 
London Calling 2025 Technology Update: Oxford Nanopore unveils path to a true multiomics future
Company news 
Cepheid and Oxford Nanopore Technologies partner to advance automated sequencing-based solutions
Company news 
Breakthrough algorithm enables partially phased, near telomere-to-telomere assembly using standard Oxford Nanopore simplex reads
Company news 
Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032
Company news APAC Rare Disease Consortium launched to advance genomic innovation and rare disease diagnosis